What Eurozone core-ESG product solution can UBS provide investors?

EURO STOXX 50 ESG tracking matters

06 aug 2019

UBS Asset Management is a leading pioneer in the sustainability-focused ETF space, and is proud to be the first provider of an ETF based on this new index by bringing you the UBS ETF Eurostoxx 50 ESG UCITS ETF. What deviation from the original non-ESG variant could the investor potentially experience?

Placing this sustainability overlay on the largest blue-chip index in Europe has delivered a daily returns correlation of 0.999 and tracking difference since 2012 of 8 basis points per annum when comparing the EURO STOXX 50 ESG Index to the standard benchmark2. Investors can now build portfolios using core ESG-filtered building blocks that show a minimal performance divergence from standard non-ESG compliant benchmarks.


Discover our indexing solutions

Important legal information

To proceed, please confirm that you are a professional / qualified / institutional client and investor.


This content is for professional clients only. It is not to be distributed to or relied upon by Retail Clients under any circumstances.

Other countries:

Views and opinions expressed are presented for informational purposes only and are a reflection of UBS Asset Management’s best judgment at the time a report or other content was compiled. UBS specifically prohibits the redistribution or reproduction of this material in whole or in part without the prior written permission of UBS and UBS accepts no liability whatsoever for the actions of third parties in this respect. The information and opinions contained in the content of this webpage have been compiled or arrived at based upon information obtained from sources believed to be reliable and in good faith but no responsibility is accepted for any errors or omissions. All such information and opinions are subject to change without notice but any obligation to update or alter forward-looking statement as a result of new information, future events, or otherwise is disclaimed. Source for all data/charts, if not stated otherwise: UBS Asset Management.

Any market or investment views expressed are not intended to be investment research. Materials have not been prepared to address requirements designed to promote the independence of investment research and are not subject to any prohibition on dealing ahead of the dissemination of investment research. The information contained in this webpage does not constitute a distribution, nor should it be considered a recommendation to purchase or sell any particular security or fund. The materials and content provided will not constitute investment advice and should not be relied upon as the basis for investment decisions. As individual situations may differ, clients should seek independent professional tax, legal, accounting or other specialist advisors as to the legal and tax implication of investing. Plan fiduciaries should determine whether an investment program is prudent in light of a plan's own circumstances and overall portfolio. A number of the comments in the content of this webpage are considered forward-looking statements. Actual future results, however, may vary materially. Past performance is no guarantee of future results. Potential for profit is accompanied by possibility of loss.

© UBS 2021 The key symbol and UBS are among the registered and unregistered trademarks of UBS.